What Analysts Think Is Shifting The Story For Insulet (PODD) And Its Edge Now [Yahoo! Finance]
Insulin Pump Market Insights $2.1B Revenue from Insulet, 500,000+ U.S. Users and 47.8% Adoption in Canada Driven by Government Funding [Yahoo! Finance]
Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care
Insulet (NASDAQ:PODD) had its price target lowered by analysts at Stifel Nicolaus from $370.00 to $350.00. They now have a "buy" rating on the stock.
Insulet Corporation (PODD): A Bull Case Theory [Yahoo! Finance]